市場調查報告書
商品編碼
1483050
全球生物醫用紡織品市場2024-2031Global Biomedical Textiles Market 2024-2031 |
生物醫用紡織品市場規模、佔有率和趨勢分析報告,依纖維類型(不可生物分解和可生物分解)、織物類型(無紡和機織)以及應用(非植入式和手術縫合線),預測期(2023-2030)
生物醫用紡織品市場預計在預測期內(2023-2030)將以 6.2%的年複合成長率成長。市場的成長歸功於全球技術的進步。紡織技術的進步使得紡織品的生產具有更高的抗菌和清潔能力,推動了市場的成長。據 MDPI 表示,到2023年 9月,聚酯(PET)等紡織品中的微塑膠將引起重大關注。研究表明,每克紡織品在洗滌過程中可釋放多達 72,000 根微塑膠纖維,纖維長度中位數範圍為 165 至 841 μm。每天有超過20,000 根纖維被河流帶到下游,在海洋表面檢測到每平方公里多達 213,200 根纖維。塑膠垃圾是一場全球性危機,這促使人們轉向使用可自然分解的材料。
Biomedical Textiles Market Size, Share & Trends Analysis Report by Fiber Type (Non-Biodegradable and Biodegradable), by Fabric Type (Non-Woven and Woven), and by Application (Non-Implantable and Surgical Sutures) Forecast Period (2023-2030)
Biomedical textiles market is anticipated to grow at a CAGR of 6.2% during the forecast period (2023-2030). The market's growth is attributed to technological advancements across the globe. Textile technological improvements have enabled the production of textiles with improved antibacterial and cleaning capabilities, driving market growth. According to the MDPI, in September 2023, microplastics from textiles such as polyester (PET) pose a significant concern. Studies indicate that up to 72,000 microplastic fibers per gram of textile can be released during washing, with median fiber lengths ranging from 165 to 841 μm. Over 20,000 fibers per day are carried downstream by river and up to 213,200 fibers per square kilometer have been detected on the ocean's surface. Plastic littering is a global crisis, which is prompting a transition towards materials that degrade in nature.
Furthermore, Bio-based and biodegradable polymers are becoming increasingly popular in the textile industry. The clothing sector is expected to be the main contributor to the growth of this market in the next decade. Biodegradable plastics are the ideal choice when the product or litter is unintentionally disposed of in nature, where aerobic or anaerobic digestion and composting are the most suitable methods of disposal.
The global biomedical textiles market is segmented on the fiber type, fabric type, and application. Based on the fiber type, the market is sub-segmented into non-biodegradable, and biodegradable. Based on the fabric type, the market is sub-segmented into non-woven, and woven. Furthermore, on the basis of application, the market is sub-segmented into non-implantable, and surgical sutures. The non-biodegradable subcategory is expected to capture a significant portion of the market share within the fiber type segment. This is attributed to the increased consumption in non-implantable applications. The growing awareness of the benefits of utilizing this fiber in the healthcare sector is projected to propel market growth.
Among the fabric type, the non-woven sub-segment is expected to hold a considerable share of the global biomedical textiles market. Non-woven fabrics provide essential safety qualities such as infection prevention and disease avoidance by preventing cross-contamination and infection transmission in a medical or surgical environment. Furthermore, nonwovens have been used more and more in the creation of smart wound care devices, with features such as promoting moist wound healing conditions, minimizing skin adhesion, and controlling vapor transmission. Non-woven fabrics are commonly used in surgical dressings, bandages, and implant applications, and non-woven fabrics are utilized in a variety of biomedical textiles, including sheets, tubes, gowns, face masks, scrub suits, shoe covers, head covers, sponges, wipes, and plugs, among others. Nonwoven materials are additionally more versatile, cost-effective, disposable, and efficient than woven fabrics, leading to growing use of healthcare applications.
The global biomedical textiles market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rise in chronic wounds and surgical operations. Furthermore, increased healthcare financing and rapid growth of the healthcare business in developing nations such as India and China are boosting market revenue growth.
Global Biomedical Textiles Market Growth by Region 2023-2030
Source: OMR Analysis
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising diverse medical applications. Polyester-based materials are increasingly being used, as they are compatible with a wide range of medical applications. They can be utilized to produce tissue engineering scaffolds, wound dressings that encourage healing, biocompatible surgical implants, and treatments such as vascular reconstructive surgery and ophthalmology. According to National Institute of Health (NIH), in February 2022, Polyester-based materials are used in a variety of medical applications, including hard and soft tissue engineering, wound dressings, surgical implants, vascular reconstructive surgery, ophthalmology, and prevention of multi-resistant infection. The usage of polyester materials in the medical field has increased by at least 20.0% since the start of the COVID-19 pandemic, with 25.0%-50.0% of all medical applications using polyester materials and the remaining percentage being provided by other types of natural or synthetic polymers, such as 25.0% polyolefins in personal protection equipment (PPE).
The major companies serving the global biomedical textiles market include Cardinal Health, DSM, Essity AB, HARTMANN USA, Inc., and Integra LifeSciences Corp., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2019, Paul Hartmann AG acquired Safran Coating, the acquisition is designed to assist the expansion of new wound care solutions and improve patient quality of life.